4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-23-012532
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 8,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 2023-08-21 | Grant or award · Stock Option (right to buy) | +8,333 | 8,333 | D | ||
Loading xslF345X05/form4-08232023_050842.xml…